Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea
May 16, 2024 01:15 ET
|
Basilea Pharmaceutica AG
Allschwil, Switzerland, May 16, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial...
Aegon appoints Duncan Russell to succeed Matt Rider as Chief Financial Officer
May 16, 2024 01:02 ET
|
Aegon Ltd.
The Hague, May 16, 2024 - Aegon today announces the appointment of Duncan Russell (1978) as Chief Financial Officer (CFO), effective September 1, 2024. Duncan will succeed Matt Rider (1963), who will...
Vastned Belgium: Application of article 7:97 BCAC by the Board of Directors of Vastned Belgium
May 16, 2024 01:01 ET
|
Vastned Belgium
The board of directors of Vastned Belgium NV (Euronext: VASTB, “Vastned Belgium” or the “Company”) has requested the committee of independent directors of the Company (the “Committee”) to issue an...
DNO Completes Acquisition of 25 Percent of UK’s Arran Field
May 16, 2024 01:00 ET
|
DNO ASA
Oslo, 16 May 2024 – DNO ASA, the Norwegian oil and gas operator, today announced the completion of the acquisition of a 25 percent interest in the Arran field on the UK Continental Shelf by the...
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports positive Phase I results for its dual GLP-1/GIP receptor agonist CT-388 in people with obesity
May 16, 2024 01:00 ET
|
F. Hoffmann-La Roche Ltd
Over 24 weeks, a once-weekly subcutaneous injection of CT-388 achieved a clinically meaningful and statistically significant mean placebo-adjusted weight loss of 18.8% (p < 0.001) At week 24, 100%...
KBC Group: First-quarter result of 506 million euros
May 16, 2024 01:00 ET
|
KBC Groep
‘We recorded a net profit of 506 million euros in the first quarter of 2024. Compared to the result of the previous quarter, our total income benefited from several factors, including higher net...
Aegon trading update for first quarter 2024
May 16, 2024 01:00 ET
|
Aegon Ltd.
The Hague, May 16, 2024 - Please click here to access all 1Q2024 Trading Update related documents. EUR 256 million operating capital generation before holding funding and operating expenses, on...
Lassila & Tikanoja plans to accelerate strategy execution and renews its Group Executive Board
May 16, 2024 01:00 ET
|
Lassila & Tikanoja plc
Lassila & Tikanoja plc Stock exchange release 16 May 2024 at 8.00 a.m. Lassila & Tikanoja plans to accelerate strategy execution and renews its Group Executive Board Lassila & Tikanoja...
Zealand Pharma Announces Financial Results for the First Quarter of 2024
May 16, 2024 01:00 ET
|
Zealand Pharma
Company announcement - No. 26 / 2024 Zealand Pharma Announces Financial Results for the First Quarter of 2024 Strong performance in the first quarter of 2024 paving the way for important data...
DNO Shares Traded Ex-Dividend
May 16, 2024 01:00 ET
|
DNO ASA
Oslo, 16 May 2024 - DNO ASA, the Norwegian oil and gas operator, today announced that the Company's shares will be traded ex-dividend effective 16 May 2024. A dividend payment of NOK 0.25 per share...
- May 15, 2024 21:43 ET Northland Power Reports First Quarter 2024 Results
- May 15, 2024 20:00 ET Chainstack Secures Strategic Investment to Accelerate Web3 Infrastructure Development